Cover Image for March T2B Comm Convo: Patient-Focused Comms
Cover Image for March T2B Comm Convo: Patient-Focused Comms
Private Event

March T2B Comm Convo: Patient-Focused Comms

Hosted by Ticket to Biotech
Zoom
Registration Closed
This event is not currently taking registrations. You may contact the host or subscribe to receive updates.
About Event

Comm Convos are free for the T2B community.

If you're not part of Ticket to Biotech, confirm you're eligible, and click this button to join before registering for this event.


PATIENT-FOCUSED COMMS: ENGAGEMENT NARRATIVES WITH JEN HELFER

Integrating the patient perspective into communications in our industry is critical, but can sometimes be overlooked amid scientific jargon and earnings reports. Jen Helfer, patient advocacy extraordinaire, will guide communicators during March's Comm Convo on authentically incorporating the patient voice in our work, from internal communications to public-facing content.

WHY ATTEND?

  • Identify ways to authentically introduce the patient perspective into communications strategies to yield narratives that are resonant and patient-centric.

  • Discover best practices for adapting corporate messaging and materials to reflect patient experiences accurately and effectively.

  • Gain insight on the preparation and ethical considerations for patient involvement in corporate materials and media pitching.

  • Uncover strategies to engage patient communities in enhancing employee understanding and connection.

  • Equip your comms team with practical approaches to navigate the initial steps in patient community engagement – with or without an in-house, dedicated patient advocacy function.

MEET OUR SPEAKER

Jen Helfer is passionate about meaningfully engaging patient communities to improve therapeutic development and delivery of healthcare. She has a strong background in the pharmaceutical industry, patient advocacy non-profit, and bench research. Currently she is head of patient advocacy and engagement at a late-stage biopharmaceutical company. Previously, Jen held roles at Encoded Therapeutics, VOZ Advisors, bluebird bio, and the National Brain Tumor Society. Jen also serves as a Board Member of the Massachusetts Sickle Cell Association, Scientific and Patient Advocacy Advisor to CureGSD1b Alliance, Faculty of the Professional Patient Advocates in Life Sciences, and Member of ASGCT's Patient Outreach Committee. Follow Jen on LinkedIn.